Rejuve.Bio

Rejuve.Bio is a biotech company using Artificial Intelligence to help you live longer.

This company is targeting the market for longevity, a market that Bank of America projects will be worth $600 billion by 2025. Its unique approach involves leveraging data from long-lived animal models and crowdsourced human data to accelerate the drug-discovery process.

To-date, Rejuve.Bio has pioneered the development of an effective supplement aimed at slowing the progression of Alzheimer’s. And in early tests, the company’s selectively-bred Methuselah flies lived eight times longer than control flies. This was notable, as sixty percent of fly DNA translates to primates, including shared genes involved in aging, metabolism, and cardiac function.

Team Background

Kennedy Schaal - Chief Executive Officer

Ben Goertzel - Chief AI Scientist

Co-Investors